Re Contract

Carillion PLC
10 September 2003



Carillion selected preferred bidder on

second Canadian PPP hospital project


Business and Construction Services company Carillion, in joint venture with
partners, has been selected as the preferred bidder for a new £60 million state
of the art Royal Ottawa Hospital, in Canada, to be built under the public
private partnership (PPP) initiative.


The Healthcare Infrastructure Company of Canada, comprising Carillion Canada,
Borealis Infrastructure Management and the EllisDon Corporation will now work up
final details of the project - the second hospital in Ontario chosen to be to be
delivered under the public private partnership initiative.


In addition to investing equity in the 188 bed hospital, Carillion will be
responsible for the provision of non-clinical services and a member of a
separate joint venture responsible for construction. A Carillion-led consortium
has already been chosen as preferred bidder for the William Osler Hospital in
Ontario, the first to be procured as a PPP project.


Commenting on the appointment, Carillion Chief Executive John McDonough said,
'We are delighted to have been selected as the preferred bidder for this major
new hospital, our second PPP project in Canada. Developing our healthcare
business and exporting our public private partnership and business service
skills to our international regions, is a key part of our strategy for growth


'We look forward to working closely with the Royal Ottawa Hospital to provide a
state of the art hospital and the services necessary to support the delivery of
first class healthcare.'


The redevelopment of the Royal Ottawa Hospital will see it evolve from an acute
psychiatric hospital serving the Ottawa-Carleton region into a highly
specialized facility for people with severe and persistent mental illness
throughout Eastern Ontario.


Whilst the hospital will be designed, built, owned and the facilities managed by
the private sector partnership, the delivery of mental health services remains
the responsibility of the hospital board.


The new facility will be developed on vacant land on the site so as not to
disrupt patient care during the construction phase.


For further information contact


John Denning, Director Group Corporate Affairs                01902 316384

John Davies or Paula Manning, Corporate Communications        01902 316444






                      This information is provided by RNS
            The company news service from the London Stock Exchange